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A Noncanonical Autophagy Pathway Restricts Toxoplasma gondii
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Harvard Medical School, Boston, Massachusetts, USAd; Center for Autophagy Research, Department of Internal Medicine, Department of Microbiology and Howard
Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USAe
ABSTRACT A core set of autophagy proteins is required for gamma interferon (IFN-)-mediated clearance of Toxoplasma gondii
in the mouse because of their control of several downstream effectors, including immunity-related GTPases (IRGs) and
guanylate-binding proteins (GBPs). However, these effectors are absent (i.e., IRGs) from or nonessential (i.e., GBPs) in IFN--
activated human cells, raising the question of how these cells control parasite replication. Here, we define a novel role for ubiq-
uitination and recruitment of autophagy adaptors in the strain-specific control of T. gondii replication in IFN--activated hu-
man cells. Vacuoles containing susceptible strains of T. gondii became ubiquitinated, recruited the adaptors p62 and NDP52,
and were decorated with LC3. Parasites within LC3-positive vacuoles became enclosed in multiple layers of host membranes,
resulting in stunting of parasite replication. However, LC3-positive T. gondii-containing vacuoles did not fuse with endosomes
and lysosomes, indicating that this process is fundamentally different from xenophagy, a form of autophagy involved in the con-
trol of intracellular bacterial pathogens. Genetic knockout of ATG16L or ATG7 reverted the membrane encapsulation and re-
stored parasite replication, indicating that core autophagy proteins involved in LC3 conjugation are important in the control of
parasite growth. Despite a role for the core autophagy machinery in this process, upstream activation through Beclin 1 was not
sufficient to enhance the ubiquitination of T. gondii-containing vacuoles, suggesting a lack of reliance on canonical autophagy.
These findings demonstrate a newmechanism for IFN--dependent control of T. gondii in human cells that depends on ubiq-
uitination and core autophagy proteins that mediate membrane engulfment and restricted growth.
IMPORTANCE Autophagy is a process of cellular remodeling that allows the cell to recycle senescent organelles and recapture
nutrients. During innate immune responses in the mouse, autophagy is recruited to help target intracellular pathogens and thus
eliminate them. However, the antimicrobial mediators that depend on autophagy in the mouse are not conserved in humans,
raising the issue of how human cells control intracellular pathogens. Our study defines a new pathway for the control of the
ubiquitous intracellular parasite T. gondii in human cells activated by IFN-. Recruitment of autophagy adaptors resulted in
engulfment of the parasite in multiple membranes and growth impairment. Although susceptible type 2 and 3 stains of T. gondii
were captured by this autophagy-dependent pathway, type 1 strains were able to avoid entrapment.
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Toxoplasma gondii is an obligate intracellular parasite that in-fects a wide range of mammalian hosts (1) and frequently
causes infections in humans (2). Humans are infected either
through the ingestion of oocysts shed into the environment by
their definitive host, the cat, or through ingestion of tissue cysts
from infected animals (1). In North America and Europe, three
clonal strains ofT. gondii predominate, referred to as type 1, 2, and
3 strains (3). As a zoonotic infection, the distribution of strains in
humans should mirror that of the animals by which they are in-
fected. However, despite the fact that type 2 and 3 T. gondii strains
are both common in food animals, only type 2 strains are preva-
lent in human infections, whereas type 3 strains are extremely rare
(4, 5). Conversely, type 1 strains are rare in animals yet elevated in
human infections, at least among some cohorts (4). This differen-
tial strain distribution suggests that there are strain-specific differ-
ences between the infection of humans and that of animals, al-
though the factors underlying these different outcomes remain
unclear.
T. gondii tachyzoites actively invade their host cell, invaginat-
ing the host cell plasmamembrane to create a compartment that is
permissive for parasite replication (6) while excluding most host
membrane proteins from the surrounding parasitophorous vacu-
ole membrane (PVM) (7, 8). Within this niche, the parasite rep-
licates asexually to high numbers before lysing the host cell by
egress, which is an active, parasite-driven process (9). The
parasite-containing vacuole does not fuse with endosomes or ly-
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sosomes; hence, the PVM remains LAMP-1 negative (8, 10–12).
Although T. gondii is able to survive in naive macrophages, acti-
vation with gamma interferon (IFN-) leads to the upregulation
of a variety of resistance factors that are important for control
in mice, including the immunity-related GTPases (IRGs),
guanylate-binding proteins (GBPs), reactive oxygen species, and
nitric oxide (13, 14). Recruitment of IRGs (15–17) and GBPs (18–
20) to PVs surrounding susceptibleT. gondii strains leads to clear-
ance, a process countered by parasite virulence factors that are
associated primarily with virulent type 1 strains (21).
Activation by IFN- also leads to control of parasite replication
in human cells, although the mechanism is less well understood.
Humans lack the majority of the IRGs, including those that have
been shown to localize to the PVM in mouse cells (13, 14). Addi-
tionally, deletion of a cluster of GBPs did not affect the ability of
IFN--activated human HAP1 cells to control the replication of
T. gondii (22). Instead, other studies have shown that IFN- treat-
ment of human cells can lead to growth restriction due to trypto-
phan depletion (23) and induction of cell death and premature
egress (24). However, neither of these mechanisms operates in all
cell types, suggesting the presence of multiple overlapping path-
ways for IFN--mediated control of T. gondii in human cells. Ad-
ditionally, it has been shown that the ligation of CD40 on the
surface of hematopoietic and nonhematopoietic cells is able to
eliminate intracellularT. gondii in an autophagy-dependentman-
ner (25, 26), although this mechanism is not dependent on acti-
vation by IFN- (27).
Macroautophagy is the process by which a cell digests and re-
cycles cytoplasmic contents, including protein aggregates, dam-
aged organelles, and intracellular organisms (28). The trafficking
of IRGs and GBPs to the PVM in mouse cells depends on a subset
of autophagy (Atg) proteins, including Atg5, Atg12, and Atg16L1,
but not the upstream activators of canonical autophagy (22, 29,
30). In mouse cells, the absence of these core Atg proteins results
in the aggregation of IRGs (15, 30) and GBPs (19, 31), and thus
they are not available for recruitment to the PVM. During canon-
ical autophagy, the double-membrane-bound autophagosome
normally goes on to fuse with LAMP-1-positive lysosomes (28).
However, following the delivery of IRGs and GBPs to the T. gon-
dii-containing PVM, the vacuole does not become LAMP-1 posi-
tive but instead is vesiculated and ruptures, resulting in the death
of the parasite (29, 30, 32). Thus, control of T. gondii in IFN--
activatedmouse cells does not rely on the downstreamdegradative
functions of autophagy (29).
Recently, a modification of the autophagy pathway has been
appreciated as an important armof cell-autonomous immunity to
intracellular bacteria (28, 33). Known as xenophagy, this process
targets bacteria that reside within membrane-bound vacuoles, in-
cluding Listeriamonocytogenes, Salmonella enterica serovar Typhi-
murium, and group A Streptococcus (34–37). Targeting by xe-
nophagy begins with permeation of the bacterium-containing
vacuole, followed by ubiquitination and recruitment of au-
tophagy adaptor proteins, including p62, NDP52, and optineurin,
leading to the recruitment of LC3 and the formation of an au-
tophagosome. The autophagosome then fuses with LAMP-1-
positive lysosomes, and the targetedmicrobe is degraded (28, 35).
Here, we examined whether xenophagy is also involved in the
control of T. gondii growth in IFN--activated human cells and if
there are strain-dependent differences in susceptibility to this
pathway. Additionally, we wanted to determine if autophagy
pathway proteins are required for IFN--dependent growth re-
striction of T. gondii in human cells. We found that core ATG
proteins are important in the ability of IFN--activated human
cells to restrict the growth of T. gondii. Importantly, this process
occurs independently of fusion with endosomes or lysosomes and
is not enhanced by the induction of upstream activation of au-
tophagy, indicating that it differs from both autophagy and xe-
nophagy.
RESULTS
Autophagy adaptors are recruited in a strain-specificmanner to
T. gondii in human cells. To determine whether proteins in the
xenophagy pathway are recruited to T. gondii-containing parasi-
tophorous vacuoles (PVs) in human cells, we localized ubiquitin,
p62, NDP52, and LC3 by quantitative immunofluorescence after
infection. Representative strains of type 1 (GT-1), 2 (PTG), and 3
(VEG) parasites were used to compare recruitment in IFN--
activated HeLa cells examined at 6 h postinfection. Type 1 PVs
were largely able to prevent the accumulation of ubiquitin, as few
PVs showed appreciable levels of staining of the vacuole (Fig. 1A).
However, many type 2 and 3 PVs were intensely stained with an-
tibodies to ubiquitin. This pattern of type 1 parasites preventing
recruitment and accumulation of ubiquitin held true for the other
autophagy adaptors p62 and NDP52 (Fig. 1B and C), while again
type 2 and 3 strains showed many PVs with high levels of host
protein accumulation. LC3was also recruited to high levels to type
2 and 3 PVs and largely excluded from type 1 PVs (Fig. 1D). Visual
assessment of PVs stained for the autophagy adaptors showed that
most type 1 PVswere negative for ubiquitin, while a large percent-
age of type 2 and 3 PVs were positive (Fig. 1E and F). This pattern
held true for the other autophagy adaptors p62 and NDP52 and
for LC3, with a larger percentage of type 2 and 3 than type 1
parasites positive (Fig. 1E and F). The recruitment of ubiquitin,
p62, NDP52, and LC3 depended on prior activation with IFN-
(Fig. 1G and H) but did not depend on the presence of known
parasite virulence factor ROP18, ROP17, or ROP5, inasmuch as
deletion of these factors in a type 1 background did not alter re-
cruitment (see Fig. S1A in the supplemental material). Collec-
tively, these data show that proteins associatedwith the autophagy
pathway accumulated on PVs in a strain-dependent manner in
IFN--activated human cells.
Autophagy adaptors colocalize on parasite-containing vacu-
oles. To determine if T. gondii PVs are sequentially targeted by
ubiquitin and then other members of the xenophagy pathway, we
colocalized ubiquitin with the autophagy adaptors p62, NDP52,
and LC3 on PVs. In IFN--activatedHeLa cells, ubiquitin showed
a similar pattern of colocalization with p62, NDP52, and LC3. For
ubiquitin and p62, the majority of the PVs (72.7%) were positive
for both ubiquitin and p62, while 23.7% were positive for ubiqui-
tin alone and no PVs were singly positive for p62 (Fig. 2A and B).
A similar pattern was seen with NDP52 and LC3 (Fig. 2C to F),
with between 28 and 30% of the PVs positive for ubiquitin alone,
while themajority were positive for both ubiquitin andNDP52 or
LC3. This pattern of staining is consistent with a model where
ubiquitin is recruited to the vacuole first, leading to subsequent
targeting by the other autophagy adaptors and finally recruitment
of LC3. We also colocalized the autophagy adaptors NDP52 and
p62. These proteins often completely colocalized but in some
cases were distinct (Fig. 2H). Additionally, we colocalized p62 and
LC3 (Fig. 2J) on PVs. As anticipated, about 90% of the PVs were
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FIG 1 Recruitment of autophagy adaptors to intracellular T. gondii. (A to D) Quantification of recruitment of autophagy adaptors to type 1 (GT-1), 2 (PTG),
or 3 (VEG) T. gondii in HeLa cells activated for 24 h with IFN- prior to infection and analyzed at 6 h postinfection. Data points represent the mean red
fluorescence of the respective host markers in a ROI overlapping the T. gondii vacuole. Arrowheads indicate the mean red fluorescence value of 90% of visually
(Continued)
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positive for both NDP52 and p62 (Fig. 2G) and a similar pattern
was seen with p62 and LC3 (Fig. 2I).
Canonical autophagy culminates in the fusion of the autopha-
gosome with the LAMP-1-positive lysosomes, forming an au-
tophagolysosome and thereby degrading the material within the
autophagosome (28). To determine if T. gondii-containing PVs in
human cells follow a similar route, we colocalized ubiquitin, LC3,
and LAMP-1 in IFN--activated HeLa cells at 6 h postinfection.
Surprisingly, we found that nearly all of the PVs that were positive
for ubiquitin remained negative for LAMP-1 staining (Fig. 2K and
L). The few PVs that were positive for LAMP-1 showed a very
distinctive, smooth, uniform, parasite-shaped rim of staining (see
Fig. S2 in the supplemental material); hence, we are confident that
we would have readily detected this staining if it were prevalent.
Similarly, a very small proportion of LC3-positive PVs, as detected
in HeLa cells expressing green fluorescent protein (GFP)-LC3,
were also positive for LAMP-1 (Fig. 2M and N). Together, these
findings demonstrate that in IFN--activated human cells,T. gon-
dii is targeted by a set of proteins similar to thatwhich targets other
intracellular bacteria undergoing xenophagy. However, the vast
majority of ubiquitin-positive PVs do not fuse with lysosomes,
indicating a unique pathway of trafficking for intracellular T.
gondii.
PVs are enveloped in multiple membranes in IFN--
activated human cells. Intracellular pathogens targeted by ubiq-
uitin and autophagy adaptors are often enclosed in canonical
double-membrane structures (38, 39). We examined the ultra-
structural features of T. gondii PVs at 6 h postinfection in HeLa
cells, conditions under which we saw recruitment of ubiquitin,
p62, NDP52, and LC3 in an IFN--dependent manner. In naive
cells, T. gondii PVs were surrounded by a smooth, intact PVM
(arrowhead in Fig. 3A). In IFN--activated cells, but not naive
cells, a proportion of the PVs were surrounded by multiple mem-
branes that enveloped the T. gondii PV within multiple cisternae.
These wrapped PVs often appeared to encapsulate a portion of the
host cytosol within them (Fig. 3B and C). To examine whether
these enveloped PVs were decorated with LC3, we performed
cryo-immuno-electronmicroscopy (cryo-immuno-EM) to local-
ize LC3 in naive and IFN--activated HeLa cells. We compared
the distribution of constitutively expressed GFP-LC3 HeLa cells
infected with type 3 (VEG) parasites at 6 h postinfection. In naive
cells, GFP-LC3 was seen diffusely in the infected cell, with occa-
sional membranous clusters consistent with a low level of au-
tophagy; however, LC3 did not concentrate near the PV (Fig. 4A).
In contrast, in IFN--activated cells, large accumulations of GFP-
LC3 were seen on the multiple membranes surrounding the PV
(Fig. 4B). The accumulation of membranes containing LC3 is
consistent with a model where susceptible T. gondii PVs are con-
tained within autophagosome-like structures in IFN--activated
cells. However, these LC3-positive vacuoles did not become
LAMP-1 positive, as shown by double immuno-EM labeling
(Fig. 4C). The number of membranes wrapping T. gondii PVs was
variable: in some cases, the PVM was engulfed by a double-
membrane layer, consistent with autophagy, while in other cases,
several layers of host membranes, and entrapped cytosol, sur-
rounded the PV (Fig. 4).
Parasite growth is stunted in vacuoles positive for ubiquitin
or p62. To assess the functional consequence of the targeting of
PVs by xenophagy, we examined the replication of type 3 strain
parasites within PVs that were either positive or negative for ubiq-
uitin or p62. T. gondii divides by binary fission every 6 to 8 h, and
as expected, ubiquitin-negative PVs showed a range of numbers of
parasites per vacuole, with ~40%having four ormore parasites by
24 h (Fig. 5A and B). In contrast, growth in ubiquitin-positive PVs
was significantly impaired, with ~85% having only one or two
parasites per vacuole (Fig. 5A). The restriction of growth of
ubiquitin-positive PVs was not dependent on the degradation of
tryptophan, as supplementation with exogenous tryptophan did
not change the replication of ubiquitin-positive PVs (see Fig. S5A
in the supplemental material). Similarly, p62-negative PVs
showed replication consistent with normal growth kinetics, with
~36% of the PVs containing four or more parasites. Alternatively,
p62-positive PVs were significantly restricted, with a great major-
ity, ~95%, containing one or two parasites (Fig. 5C and D). De-
spite being restricted in growth, type 3 parasites were not cleared
from IFN--activated cells (see Fig. S5B). To assess the functional
consequences of ubiquitin recruitment to other parasite strains,
we determined the percentage of parasites that were positive for
ubiquitin over time, as well as parasite replication at 24 h postin-
fection. Type 2 and 3 strains had a significantly higher percentage
of PVs positive for ubiquitin than did type 1 parasites at 6 h postin-
fection (Fig. 5E). At 24 h postinfection, the percentage of
ubiquitin-positive parasites decreased in all vacuoles; however,
~10% of the type 2 and 3 vacuoles remained positive while the
type 1 parasites were nearly completely negative (Fig. 5E). Impor-
tantly, parasites from all of the strains that were positive for ubiq-
uitin were stunted in their replication, while parasites that were
negative for ubiquitin replicated normally (Fig. 5F). Together,
Figure Legend Continued
determined positive vacuoles. Each value is the mean SEM of three experiments (***, P 0.001; *, P 0.05; Kruskal-Wallis test). (E) Immunofluorescence
localization of ubiquitin, p62, NDP52, or LC3 to the PVM inHeLa cells activated with 5 ng/ml IFN- at 6 h postinfection with type 3 (VEG) parasites. Ubiquitin
was localized with mouse MAb FK2, followed by anti-mouse IgG conjugated to Alexa Fluor 594 (red). p62 was localized with a guinea pig polyclonal antibody,
followed by anti-guinea pig IgG conjugated to Alexa Fluor 594 (red). NDP52 was localized with a rabbit polyclonal antibody, followed by anti-rabbit IgG
conjugated to Alexa Fluor 594 (red). LC3 was localized with a rabbit polyclonal antibody, followed by Alexa Fluor 594 (red). T. gondii PVM was localized with
either a rabbit polyclonal antibody to GRA7, followed anti-rabbit IgG conjugated to Alexa Fluor 488 (green), or mouse MAb tg17-113 to GRA5, followed by
anti-mouse IgG conjugated to Alexa Fluor 488 (green). Nuclei were stained with 4=,6-diamidino-2-phenylindole (DAPI) (blue). Scale bar, 5 m. (F) Visual
assessment of the percentage of host marker-positive T. gondii PVs from images used to collect the data shown in panels A to D. Each value is the mean SEM
of three experiments. (G) Quantification of recruitment of autophagy proteins to type 3 (VEG) parasites in naive or IFN--activated HeLa cells at 6 h
postinfection by fluorescence microscopy. There were two experiments and a total of six coverslips. Each value is the mean  SD. (H) Immunofluorescence
images of HeLa cells infected with type 3 (VEG) parasites at 6 h postinfection. HeLa cells were activated with 5 ng/ml IFN-. Ubiquitin was localized withmouse
MAb FK2, p62 was localized with a guinea pig polyclonal antibody, NDP52 was localized with a rabbit polyclonal antibody, and LC3 was localized with a rabbit
polyclonal antibody, followed by secondary antibodies conjugated to Alexa Fluor 488 (green) or 594 (red), as indicated. T. gondii PVMwas localized with either
a rabbit polyclonal antibody to GRA7 or mouse MAb tg17-113 to GRA5, with the opposite antibody species to the host marker, followed by anti-mouse IgG
conjugated to Alexa Fluor 488 (green) or 549 (red). Nuclei were stained with DAPI. Scale bar, 5 m. See also Fig. S1 in the supplemental material.
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these data suggest that the targeting of PVs by ubiquitin or other
adaptors in the autophagy pathway restricts the replication of all
strains of parasites in IFN--activated human cells. Thus, the ma-
jor strain-dependent difference is the much higher level of ubiq-
uitination and recruitment of autophagy adaptors to vacuoles
containing type 2 and 3 strain parasites, while type 1 parasites
avoid this fate.
Autophagy pathway KO human cells are not able to restrict
replication of ubiquitin-positive PVs.To examine the role of au-
tophagy in the growth restriction of T. gondii in IFN--activated
cells, we examined parasite growth in cells lacking ATG16L1, a
critical component of the elongation complex (28). In an experi-
ment similar to that described above, wemeasured the replication
of parasites in ubiquitin-positive PVs in wild-type, ATG16L1
knockout (KO), and complemented cells. Wild-type HeLa cells
that were activated with IFN- strongly restricted replication in
ubiquitin-positive PVs, with 92.7%of the vacuoles containing one
or two parasites (Fig. 6A and B). However, in ATG16L1 KOHeLa
cells, ubiquitin-positive PVs replicated to significantly higher
numbers, similar to the level of replication seen in ubiquitin-
negative PVs, with 66.3% of the PVs containing four or more
parasites per vacuole (Fig. 6A and B). Stunting of LC3-positive
PVs was also reversed in ATG16L1 KOHeLa cells (see Fig. S6A in
the supplemental material), as was the wrapping of parasites in
multiple membranes, as detected by EM (see Fig. S6B). Comple-
mentation of ATG16L1 expression in the KO cell line restored the
growth restriction of ubiquitin-positive PVs (Fig. 6A). To extend
this analysis, we also examined replication in IFN--activated cells
lacking ATG7, which is involved in the lipidation of LC3 (28).
ATG7 KO cells were also unable to restrict the growth of
ubiquitin-positive PVs in IFN--activatedHeLa cells (Fig. 6C and
D), while parental wild-type HeLa cells restricted parasite replica-
tion (Fig. 6C and D). ATG7 KO clone 1A6 showed a significant
defect in the control of the replication of ubiquitin-positive PVs,
with more than half of the positive PVs able to replicate to four or
more parasites per vacuole. A second ATG7 KO clone, 1A11,
showed a more modest phenotype, but ubiquitin-positive PVs
were again able to replicate to a significantly higher number than
in wild-type cells (Fig. 6C).
To examine whether the upstream activation steps of au-
tophagy are required for the recruitment of ubiquitin to PVs, we
depleted U2OS cells of Beclin 1 and ATG14 by using tetracycline-
inducible short hairpin RNA (shRNA). In cells depleted of either
Beclin 1 or ATG14 (Fig. 6F), ubiquitination of susceptible para-
sites was not decreased at 6 h postinfection (Fig. 6E). Additionally,
we activated autophagy in HeLa cells by using a Tat-Beclin 1 pep-
tide or a control Tat-scrambled peptide. Under these conditions,
ubiquitination was not increased in naive cells treated with the
Tat-Beclin 1 peptide, despite an increase in LC3-GFP puncta
(Fig. 6G and H). Additionally, treatment with the Tat-Beclin 1
peptide did not alter the percentage of ubiquitination of suscepti-
ble PVs in IFN--activated cells (Fig. 6G).
DISCUSSION
Although prior studies have shown that IFN- activation of hu-
man cells restricts the intracellular growth of T. gondii, the poten-
tial roles of autophagy and xenophagy in this process were un-
clear. Here we show that T. gondii parasites are targeted by a
noncanonical autophagy pathway in IFN--activated human cells
to restrict growth in a parasite strain-specific manner. Ubiquitin,
the autophagy adaptors p62 andNDP52, and LC3 are recruited to
high levels around PVs containing susceptible strains of T. gondii.
LC3-positive PVs were enveloped by multiple membranes that
resemble the autophagosomes surrounding group A Streptococcus
(36). However, T. gondii-containing PVs that are targeted by au-
tophagy adapters do not fuse with LAMP-1, and thus, they do not
intersect the late endosome or lysosome compartment, as is seen
with other pathogens targeted by xenophagy (27, 35). The growth
of parasites withinmembrane-encapsulated PVs was stunted, and
replication was rescued by KO of ATG16L1 or ATG7, a protein
required for elongation of the autophagosomemembrane. Collec-
tively, these findings reveal that a noncanonical autophagy path-
way targets T. gondii parasites in a strain-specific manner in IFN-
-activated human cells.
Our findings define a new mechanism for IFN--dependent
control of T. gondii in human cells that depends on the ubiquiti-
nation and recruitment of a set of proteins involved in the au-
tophagy pathway, including p62,NDP52, andLC3. These proteins
were recruited in a strain-dependent manner to the PVs of type 2
and 3 parasites, while type 1 parasites largely resisted this recruit-
ment. Importantly, parasite growth was stunted in all ubiquitin-
positive vacuoles, regardless of the strain type; thus, the major
difference in type 1 strains is their ability to avoid ubiquitination
and recruitment of autophagy adaptors. The recruitment of the
autophagy proteins was dependent on prior stimulation with
IFN-, which may be due to the requirement for an IFN-induced
protein or to a general upregulation of autophagy adaptors by
IFN- or through the p38 mitogen-activated protein kinase
pathway (40, 41). Ubiquitination and recruitment of au-
tophagy adaptors did not require GBPs, consistent with the
lack of a demonstrable role for these proteins in the control of
T. gondii in IFN--activated human cells (22). Additionally, pre-
viously described mouse virulence factors ROP5, ROP18, and
ROP17 did not contribute to the strain-dependent differences in
the recruitment of autophagy proteins in human cells. Recruit-
ment of autophagy adaptors and LC3 led to parasite growth inhi-
bition, and this was dependent on autophagy proteins ATG16 and
ATG7. Since ATG5, ATG12, and ATG16 contribute to a tripartite
complex needed for phagophore elongation (28), it is likely that all
three proteins are essential to this process, similar to the situation
FIG 2 Colocalization of autophagy adaptors in intracellular T. gondii. (A, C, E, G, I, K, M) Quantification of colocalization of host cell markers. The percentage
of the subset of type 3 (VEG) PVs that were positive for either a single host cell marker or both was determined by microscopic examination in HeLa cells or in
HeLa cells expressing LC3-GFP (M) activated with 5 ng/ml IFN-. At 6 h postinfection, cells were fixed and stained for immunofluorescence localization of host
cell markers as described below. Each value is the mean SEM of three experiments. (K) Mean values SD of two experiments with three internal replicates
each. (B, D, F, H, J, L, N) Representative images of colocalization of autophagy adaptors surrounding T. gondii. Ubiquitin was localized with mouse MAb FK2,
p62 was localized with a guinea pig polyclonal antibody, NDP52 was localized with a rabbit polyclonal antibody, LC3 was localized with a rabbit polyclonal
antibody, LAMP-1 was localized with a rabbit polyclonal antibody, and GFP-LC3 was localized with mouse MAb 3E6 to GFP, followed by secondary antibodies
conjugated with either Alexa Fluor 488 (green) or 594 (red), as indicated. Nuclei were stained with DAPI. Scale bars, 5 m. See also Fig. S2 in the supplemental
material.
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FIG 3 Engulfment ofT. gondii (Tg) bymultiplemembranes in IFN--activated cells. (A) Transmission EM reveals the normal architecture of the PVMof a type
3 (VEG) parasite in a naiveHeLa cell at 6 h postinfection. (B, C) Additionalmembranes surround the PVMof a type 3 (VEG) parasite inHeLa cells activated with
5 ng/ml IFN- at 6 h postinfection. The arrows indicate the parasite membrane, the arrowheads indicate the PVM, and the asterisks indicate additional
membranes. Scale bars, 500 nm. See also Fig. S3 in the supplemental material.
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in mice (29). In mouse cells activated with IFN-, upstream me-
diators of the autophagy pathway, including Atg14L, Ulk1, and
Ulk2, are not required for control of T. gondii (29). Here we dem-
onstrate that in human cells depletion of two upstreammediators
of autophagy, Beclin 1 and ATG14, does not alter the recruitment
of ubiquitin to susceptible strains of T. gondii and that induction
of autophagy with a peptide derived from Beclin 1 was not suffi-
cient to trigger the recruitment of LC3 to T. gondii PVs. Collec-
tively, these data indicate that the autophagy elongation complex
is required for growth restriction of T. gondii in PVs targeted by
ubiquitin. In contrast, upstream components of the autophagy
pathway are unlikely to be involved, indicating that these pro-
cesses do not rely on classical autophagy.
In contrast to our findings, previous studies have failed to find
a major role for ATG proteins in the IFN--mediated control of
T. gondii in human cells. One such study reported normal control
FIG 4 LC3 and LAMP-1 localization in cells infected with T. gondii (Tg). Cryo-immuno-EM localization of GFP-LC3 and LAMP-1 in naive (A) or IFN-
(5 ng/ml)-activated (B, C) HeLa cells infected with type 3 (VEG) parasites at 6 h postinfection. (A, B) GFP-LC3 was localized with a rabbit polyclonal antibody
to GFP, followed by goat anti-rabbit IgG conjugated to 18-nm gold. (C) LAMP-1 was localized with rabbit MAb D2D11, followed by donkey anti-rabbit IgG
conjugated to 12-nm gold (small white arrowheads), GFP-LC3 was localized with a goat polyclonal antibody to GFP, followed by donkey anti-goat IgG
conjugated to 18-nm gold (large white arrowheads). Arrowheads indicate parasite membranes, arrows indicate the PVM, and asterisks indicate additional
membranes. Scale bars, 500 nm. See also Fig. S4 in the supplemental material.
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ofT. gondii replication in IFN--activated human cells depleted of
ATG5; however, this result may have been due to the use of a type
1 strain (24), which we have shown is resistant to this pathway, or
incomplete knockdown by small interfering RNA. Another study
failed to observe a role for ATG16L1 in the control of a type 2
strain ofT. gondii in IFN--activated human cells, as detected by a
parasite luciferase-based growth assay (22). Our ability to discern
a role for ATG proteins in IFN--treated human cells may be due
to our use of a more sensitive assay that distinguishes the fate of
individual parasite-containing vacuoles. By examining individual
vacuoles, we demonstrate that type 1 strain parasites largely avoid
the recruitment of ubiquitin and autophagy adaptors and that
therefore their replication is unimpeded. In contrast, a large frac-
tion (i.e., 20 to 30%) of vacuoles containing type 2 and 3 parasites
recruit these adaptors and are stunted in growth. Although sus-
ceptible type 2 and 3 strains recruit LC3 to a portion of the PVs,
not all parasites are affected by this growth-restricting pathway.
Thus, incomplete targeting may explain why the role of ATG pro-
teins was not evident in assays that monitored total population
growth. The reasons for the observed heterogeneity in the target-
ing of susceptible PVs are unclear, but similar finding have been
reported for bacterial pathogens that are targeted by xenophagy
(42). Collectively, these findings indicate that recruitment of au-
tophagy adaptors leads to strain-specific restriction of T. gondii
growth, although other host factors also contribute to the control
of parasite replication in IFN--activated human cells.
Despite the findings that the same core set of Atg proteins is
essential in mouse and human cells, the pathways they control are
quite different. In mouse cells, Atg3, Atg7, and a complex consist-
ing of Atg5, Atg12, and Atg16 are required for the recruitment of
IRGs and GBPs, which results in vesiculation of the PVM and
destruction of the parasite (22, 29, 30). In contrast, the present
study shows that in human cells, ATG16L1 andATG7 are required
for a process that results in wrapping of the PV in multiple host
membranes. Membrane envelopment in human cells did not led
to vacuole destruction or delivery to lysosomes but rather re-
stricted growth. The PV surrounding T. gondii is normally porous
to small molecules (43), suggesting that this may be an important
FIG 5 Impaired replication of T. gondii in vacuoles targeted by autophagy adaptors. Quantification of parasite replication in vacuoles positive for ubiquitin (A)
or p62 (C). The number of parasites per vacuole was assessed by immunostaining for parasite surface or host cell markers, followed by epifluorescence
microscopy for type 3 (VEG) parasites in IFN--activated HeLa cells at 24 h postinfection. Each value is the mean SEM of three experiments (***, P 0.001;
two-way ANOVA). (B, D) Representative immunofluorescence images of vacuoles positive or negative for ubiquitin or p62. (B) Ubiquitin was localized with
mouseMAb FK2, followed by goat-anti mouse IgG conjugated to Alexa Fluor 594 (red). Parasites were localized with a rabbit polyclonal antibody to tachyzoites,
followed by goat anti-rabbit IgG conjugated to Alexa Fluor 488 (green). (D) p62 was localized with a guinea pig polyclonal antibody, followed by anti-guinea pig
IgG conjugated to Alexa Fluor 594 (red).T. gondii (Tg) was localized withMAbDG52 to SAG1, followed by goat anti-mouse IgG conjugated to Alexa Fluor 488
(green). Nuclei were stained with DAPI. Scale bars, 5 m. (E) Quantification of recruitment of ubiquitin to type 1 (GT-1), 2 (PTG), and 3 (VEG) parasites at 6
or 24 h postinfection in IFN--activated HeLa cells. Each value is the mean SEM of three experiments (**, P 0.01; *, P 0.05; one-way ANOVA). Strains
were compared to each other at the same time point. (F) Quantification of parasite replication of type 1 (GT-1), 2 (PTG), and 3 (VEG) parasites in vacuoles
positive or negative for ubiquitin at 24 h postinfection in IFN--activatedHeLa cells. Replicationwas quantified as described above. The total numbers of positive
vacuoles counted for replication were as follows: type 1, 90; type 2, 450; type 3, 450 (**, P  0.01; *, P  0.05; two-way ANOVA). See also Fig. S5 in the
supplemental material.
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FIG 6 Replication of T. gondii in autophagy-deficient HeLa cells. (A) Replication of type 3 (VEG) T. gondii in vacuoles positive for ubiquitin in IFN--activated
wild-type (WT), ATG16L1KO (clone E6), or ATG16L1-complemented (WT/Comp or E6/comp) host cell strains at 24 h postinfection. Each value is themean
SEM of three experiments (***, P 0.001; two-way ANOVA). (B) Representative fluorescence images of T. gondii vacuoles in ATG16L1 KO or complemented
strains.Ubiquitinwas localizedwithmouseMAbFK2, followed by goat anti-mouse IgG conjugated toAlexa Fluor 594 (red). Parasiteswere localizedwith a rabbit
polyclonal antibody to tachyzoites (Tg), followed by goat anti-rabbit IgG conjugated to Alexa Fluor 488 (green). Scale bars, 5 m. (C) Replication of type 3
(VEG) T. gondii positive for ubiquitin in IFN--activated ATG7 KO HeLa cells at 24 h postinfection. Each value is the mean SEM of three experiments (***,
P 0.001; two-way ANOVA). (D) Representative images of T. gondii vacuoles in wild-type (WT) HeLa cells or ATG7 KO clones (1A6 or 1A11). Ubiquitin was
localized withmouseMAb FK2, followed by goat anti-mouse IgG conjugated to Alexa Fluor 594 (red). Parasites were localized with a rabbit polyclonal antibody
to tachyzoites (Tg), followed by goat anti-rabbit IgG conjugated to Alexa Fluor 488 (green). Scale bars, 5m. (E) Quantification of recruitment of ubiquitin to
(Continued)
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route for nutrient uptake from the cytosol. Therefore, the envel-
opment of the PV in multiple membranes may impair the acqui-
sition of essential nutrients or lipids. Consistent with this, deletion
of ATG16L1 or ATG7 led to loss of membrane envelopment and
reversal of growth inhibition in IFN--activated HeLa cells. Al-
though human cells can control T. gondii in response to IFN- by
induction of IDO and the depletion of host cell tryptophan (23),
tryptophan supplementation did not rescue the growth repression
associated with ubiquitin recruitment. Additionally, although we
did observe a low level of cell death and T. gondii egress upon the
activation of human cells with IFN-, this outcome was not strain
dependent and is unlikely to account for the findings presented
here. Instead, our findings reveal a novel pathway of ATG-
dependent membrane recruitment that leads to inhibition of par-
asite replication.
The recognition of bacteria by autophagy has been associated
with a reduction in the burden of infectious organisms because of
the fusion of the autophagosome with lysosomes and subsequent
killing of the bacteria (35). Although some bacteria, such as My-
cobacterium tuberculosis,Chlamydia trachomatis, and adherent in-
vasive Escherichia coli, are able to manipulate this pathway to re-
duce their fusion with and/or acidification of lysosomes (35, 44–
47), they have all been reported to acquire LAMP-1 on the
autophagosome to a substantial degree (48). Similarly, activation
of CD40 on mouse and human cells leads to recruitment of au-
tophagy adaptors and delivery of T. gondii to lysosomes, where
they are destroyed by a process that is independent of IFN- (25–
27). In contrast, we demonstrate that, in human cells, LAMP-1
does not accumulate on PVs targeted by autophagy, nor are sus-
ceptible parasites cleared from IFN--activated HeLa cells. This
result suggests that susceptible PVs targeted by LC3 do not fuse
with either late endosome or lysosomes, since both host compart-
ments are enriched in this membrane marker (49). It has been
shown that T. gondii parasites actively invade host cells and estab-
lish a PV that does not intersect the endocytic pathway, fuse with
endosomes or lysosomes, or become acidified (8, 10–12). Two
models have been proposed to explain howT. gondii avoids fusion
with the host endomembrane system: (i) an active block in endo-
cytic fusion and (ii) absence of fusion-promoting signals on the
PVM (9). Our data suggest that prevention by the parasite of
LAMP-1 accumulation on the PV is an active process, since PVs
that are targeted by ubiquitin, autophagy adaptors, and LC3 still
do not fuse with endosomes or lysosomes. In this regard, the pres-
ence of T. gondii PVs enveloped bymultiple membranes may rep-
resent a process of targeting for autophagosome engulfment in the
absence of delivery to lysosomes.
Here we define a new pathway for cell-autonomous immune
control of T. gondii in IFN--activated human cells. The recruit-
ment of autophagy proteins and stunting of targeted PVs occur in
a strain-specific manner, suggesting that there are novel virulence
factors that target this mechanism of cell-autonomous immunity
in human cells. Understanding the mechanisms by which para-
sites are able to thwart human innate immune defenses may in-
fluence the design of novel therapeutics to treat toxoplasmosis.
MATERIALS AND METHODS
(For additional materials and methods used in this study, see Text S1 in
the supplemental material.)
Parasite strains and culture. Type 1 (GT-1:ATCC 50853), 2 (PTG:
ATCC 50841), and 3 (VEG) (4) parasite strains were cultured in human
foreskin fibroblasts (HFFs) grown in Dulbecco’s modified Eagle’s me-
dium (DMEM) supplemented with 10% fetal bovine serum (FBS; Hy-
Clone), 2 mM glutamine (Sigma), 10 mM HEPES (pH 7.5; Sigma), and
20 g/ml gentamicin at 37°C in 5% CO2. For all parasite infections, par-
asites were allowed to egress naturally and were harvested as described
previously (50). All strains and host cell lines were determined to be my-
coplasma negative with the e-Myco plus kit (Intron Biotechnology).
Cell culture. HeLa cells were grown in minimum essential medium
(Sigma) supplemented with 10% defined FBS (HyClone), 4 mM glu-
tamine, and 10mMHEPES, pH7.5.HeLa cells stably expressing LC3-GFP
were grown in the above medium supplemented with 100 g/ml G418
(Sigma). ATG16L1 and ATG7 KO HeLa cells were grown in DMEM
(Gibco) supplemented with 10% defined FBS (HyClone), 4 mM glu-
tamine, and 10 mM HEPES, pH 7.5 (Sigma). U2OSTetR, U2OSTetR/
shATG14, and U2OSTetR/shbeclin 1 cells were cultured in Iscove’s modi-
fied Dulbecco’s medium (Gibco) supplemented with 10% defined,
tetracycline-free FBS (HyClone), 4 mM glutamine, and 10 mM HEPES,
pH 7.5.
Autophagy-deficient cell lines. ATG16L1-deficient HeLa cells were
generated with the px330 plasmid CRISPR system as described previously
(51). HeLa cells were transfected with the Cas9 vector containing
ATG16L1-specific subgenomicRNA (sgRNA) sequences located in exon 2
of ATG16L1 isoform 1 by using FuGENE (Roche) according to the man-
ufacturer’s instructions. At 48 h posttransfection, cells were plated in lim-
iting dilution in 96-well plates to isolate single cell clones. To confirm
complete ATG16L1 KO, DNA was extracted with DNeasy (Qiagen) and
ATG16L1 exon 2was PCRamplified and sequenced to identify cloneswith
frameshift mutations in all loci. ATG7 HeLa cells were obtained from the
Genome Engineering and iPSC Center at the Washington University
School of Medicine. HeLa cells were transfected with the Cas9 vector
containing ATG7-specific sgRNA sequences located in exon 3 of ATG7.
Cells were plated in limiting dilution in 96-well plates to isolate single cell
clones. To confirmcompleteATG16L1KO,DNAwas extracted andATG7
exon 3 was PCR amplified and sequenced to identify clones with frame-
shift mutations. To generate the ATG16L1 rescue line, ATG16L1 cDNA
was inserted into a modified CSGW lentiviral vector and cotransfected
into HEK293T cells with a vesicular stomatitis virus G protein expression
plasmid and a gag-pol expression plasmid. After 48 h,medium containing
lentivirus was harvested and used to infectATG16L1KOHeLa cells. After
48 h, 3 g/ml blasticidin was added to select for cells with a stably inte-
Figure Legend Continued
type 3 (VEG) parasites in IFN--activated (5 ng/ml) U2OS cells treated with tetracycline-inducible shRNA in the presence or absence of tetracycline at 6 h
postinfection. Each value is the mean SEM of three experiments (n.s., not significant; two-way ANOVA). (F) Expression of Beclin 1 and ATG14 detected by
Western blotting of lysates from parental U2OS cells or tetracycline-induced shRNA knockdown of Beclin 1 and ATG14. Beclin 1 and ATG14 were detected
with a rabbitMAb (Beclin 1) or a rabbit polyclonal antibody (ATG14), followed by LiCor IRDye 800CWgoat anti-rabbit IgG (green). Actin was used as a loading
control and detected with mouse MAb C4, followed by LiCor IRDye 680CW goat anti-mouse IgG (red). Arrowheads indicate Beclin 1 or ATG14 protein. The
values to the left aremolecular sizes in kilodaltons. (G)Quantification of recruitment of ubiquitin to type 3 (VEG) parasites in naive or IFN--activatedHeLa cells
treated with 25MTat-Beclin 1, Tat-scrambled peptide, or Opti-MEM at 6 h postinfection. Each value is themean SD of two experiments with three internal
replicates and a total of six coverslips. n.s., not significant; Kruskal-Wallis test. (H) Representative fluorescence images of HeLa cells expressing LC3-GFP treated
with 25 M Tat-Beclin 1 or Tat-scrambled peptide for 3 h. GFP-LC3 was localized with mouse MAb 3E6 against GFP, followed by goat anti-mouse IgG
conjugated to Alexa Fluor 488. Scale bar, 20 nm. See also Fig. S6 in the supplemental material.
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grated ATG16L1-expressing provirus. U2OSTetR, U2OSTetR/shATG14,
andU2OSTetR/shbeclin 1 cells were generated as previously described (52).
Western blot analysis.U2OS cells forWestern blot analysis were lysed
in 1% NP-40 lysis buffer (1% NP-40, 150 mM NaCl, 25 mM Tris, 1 mM
EDTA, pH 7.4) with protease inhibitors. Samples were resuspended in
denaturing SDS sample buffer, resolved on a 10% acrylamide gel, and
transferred to a nitrocellulose membrane. Blots were probed with rabbit
monoclonal antibody (MAb) D40C5 to Beclin 1 (Cell Signaling), rabbit
anti-ATG14 antibody (Cell Signaling), or MAb C4 against actin (Milli-
pore), followed by goat anti-rabbit or -mouse IgG conjugated to IRDye
680 or 800, as indicated (LI-COR).
Antibodies. The T. gondii PVM was localized with mouse MAb tg17-
113 against GRA5 (53) or rabbit polyclonal serum to GRA7 (54). Intra-
cellular T. gondii parasites were localized with either mouse MAb DG52
against SAG1 or rabbit polyclonal serum to type 1 (RH) strain tachyzoites
(this serum cross-reacts with all of the T. gondii strains used here). Ubiq-
uitin was localized with mouse MAb FK2 (EMD Millipore). p62 was lo-
calized with a guinea pig polyclonal antibody specific to the C terminus
(Progen). NDP52 was localized with a rabbit polyclonal antibody (Pro-
teintech). LC3 was localized with a rabbit polyclonal antibody (MBL).
LAMP-1 was localized with rabbitMAbD2D11 (Cell Signaling). GFP was
localized with a rabbit polyclonal antibody (Abcam) or mouse MAb 3E6
(Life Technologies). Actin was localized with mouse MAb C4 (Invitro-
gen). Secondary antibodies conjugated to Alexa Fluor 488 or 594 (Invit-
rogen) were used for detection by immunofluorescence.
Autophagy induction. Tat-Beclin 1 and Tat-scrambled peptides
(AnaSpec Inc.) were resuspended in sterile H2O and stored at 80°C.
Peptides were resuspended to 25 M in Opti-MEM (Gibco) acidified to
pH 7 with HCl. Cells were washed with PBS, and peptides were added to
cells at 3 h preinfection.
Beclin 1 and ATG14 knockdown. Tetracycline-inducible shRNA-
treated U2OS cells were cultured in the presence of 1 g/ml anhydrotet-
racyline (Clontech) for 5 days. Cells were then seeded onto glass cover-
slips, allowed to adhere in the presence of anhydrotetracyline overnight,
and then activated with a final IFN- concentration of 5 ng/ml for 24 h
prior to infection. Cells for Western blot analysis were harvested at the
same time as fixation for T. gondii-infected cells.
Immunofluorescence assays.Cellmonolayers were fixed in 4% form-
aldehyde, permeabilized with 0.05% saponin, and stained with primary
and secondary antibodies as described previously (55). Samples were vi-
sualized with a Zeiss Axioskop 2 MOT Plus microscope equipped for
epifluorescence and with a 63 Plan-Apochromat lens, numerical aper-
ture 1.40 (Carl Zeiss, Inc., Thornwood, NY). Images were acquired with
an AxioCam MRm camera (Carl Zeiss, Inc.) with AxioVision v4.6 and
processed with similar linear adjustments for all samples in Photoshop
CS4 v9.
Fluorescence quantification of positive vacuoles. To determine the
mean fluorescence of each hostmarker on the parasite vacuole, HeLa cells
were activated with 5 ng/ml IFN- for 24 h, infected with parasites for 2 h,
washed three times with PBS, and recultured with complete medium.
Cells were fixed at 6 h postinfection, and parasites and host cell markers
were localized with antibodies as described previously. On each of three
coverslips, five random fields were captured for a total of 15 images under
each condition. This was repeated for three separate experiments for a
total of 45 images analyzed under each condition. With the Velocity soft-
ware (Velocity Software Inc.), a region of interest (ROI) was drawn over
the T. gondii vacuole and the mean red fluorescence in this area was ob-
tained. Three background ROIs, two in infected cells and one in a nonin-
fected cell, were also obtained. These three background values were aver-
aged and subtracted from the mean fluorescence intensity of each ROI.
The data shown are for each ROI with the background subtracted, and all
negative values were set to zero.
Visual assessment of positive vacuoles. To examine the distribution
of host markers, samples were fixed at 6 h postinfection in HeLa cells
activated as described above. After staining with appropriate primary and
secondary antibodies, recruitment was determined by first visualizing the
parasitophorous vacuole or parasite marker and then assessing whether
there was an accumulation of host protein around each parasite. The
percentage of positive parasites was determined from at least 100 parasites
per coverslip.
Intracellular replication assays. To examine intracellular replication
of T. gondii, IFN--activated HeLa cells were infected with parasites for
2 h, washed three times with PBS, and fed with fresh medium. Cells were
fixed at 24 h postinfection, and intracellular parasites were localized with
MAb DG52 or a rabbit polyclonal antibody to RH strain tachyzoites.
Secondary antibodies recognizing the species of primary antibody conju-
gated to Alexa Fluor 488 or 594 were used as indicated. The number of
parasites per vacuole was determined by manual counting on a fluores-
cence microscope. The number of parasites per vacuole was determined
from at least 50 vacuoles on three individual coverslips.
Transmission EM. HeLa cells were activated with 5 ng/ml IFN- for
24 h prior to infection. Where indicated, cells were infected with freshly
egressed parasites for 2 h, washed three times with PBS, and then fixed at
6 h postinfection. For ultrastructural analysis, cells were fixed in 2%
paraformaldehyde--2.5%glutaraldehyde (Polysciences) in 100mMphos-
phate buffer (pH 7.2) for 1 h at room temperature, processed, and exam-
ined as described previously (30, 32). For immuno-EM, HeLa cells stably
expressing GFP were fixed in 4% paraformaldehyde--0.05% glutaralde-
hyde (Polysciences) in 100 mM piperazine-N,N[prime]-bis(2-
ethanesulfonic acid) (PIPES)--0.5 mMMgCl2 (pH 7.2) for 1 h at 4°C and
processed as described previously (32). Sections were stained with rabbit
polyclonal antibody to GFP (Abnova), goat polyclonal antibody to GFP
(Abcam), or rabbit MAb D2D11 against LAMP-1 (Cell Signaling), fol-
lowed by gold-conjugated secondary antibodies (Jackson ImmunoRe-
search Laboratories). Sections were stained and viewed with a JEOL
1200EX transmission electron microscope (JEOL USA) as described pre-
viously (32). Parallel controls with the primary antibodies omitted were
consistently negative at the concentration of colloidal-gold-conjugated
secondary antibodies used in these studies.
Statistics. Statistical analyses were conducted with PRISM (Graph-
Pad). Results were compared with the Kruskal-Wallis test or one- or two-
way analysis of variance (ANOVA), as noted. P values of 0.05 were
considered significant. Data were graphed as the mean  the standard
error of the mean (SEM) or the standard deviation (SD), as indicated in
the figure legends.
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